FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2575877568> ?p ?o ?g. }

• W2575877568 endingPage "4401" @default.
• W2575877568 startingPage "4401" @default.
• W2575877568 abstract "Abstract Background: In Hodgkin Lymphoma (HL) elevated neutrophil (HL-N) count is a well-known negative prognostic factor but its biological meaning is not elucidated. Our previous work showed that HL-N are dysfunctional and can suppress T-cell activation in vitro, as consequence of increased amount of Arginase-1 (Arg-1). Aim: Investigating clinical meaning of arginase increase in HL, correlating its amount to features at diagnosis, including some semiquantitative parameters of 18-FDG- PositronEmission Tomography (PET) acquired with a novel operator-independent algorithm. Material and methods: We prospectively measured soluble Arg-1 (s-Arg-1) in 135 sera obtained from 90 patients with HL, distinguished in a training set (N=35) and a validation set (N=55) and 20 healthy participants. In the training set, blood was taken at three fixed time-points prior, during, and after first-line therapy. In the first ten patients, a correlation between s-Arg-1 and semiquantitative parameters of PET at diagnosis was explored, including the Metabolic Tumor Volume (MTV) and the Total Lesion Glycolysis (TLG). Briefly, our group developed ad hoc tool independent from the operator: PET images are represented as a graph in which the voxels are its nodes and the edges are defined by a cost function which maps a change in image intensity to edge weights. This approach is an efficient and accurate method to segment lesion in low contrast images characterized by noise and weak edges as metabolic images (Stefano, 2013). Results: s-Arg-1 was increased in HL patients compared to healthy subjects, reduced after therapy in responders and increased in relapsed patients (p<0.0001). s-Arg-1 was positively correlated to the amount of Neutrophils and Arg-1 in N detected by RT-PCR. A cut-off level of 205 ng/mL for Arg-1 was chosen (equal to 2 times the 95th percentile in controls and ROC value with sensitivity and specificity of at least 80%) to predict response status at 24 months. In the training set, 32% patients had high s-Arg-1, 24% had positive PET-2 and were addressed to an early salvage therapy accordingly to BEACOPP scheme. A level of 205 ng/mL s-Arg-1 resulted in 83% (95% C.I. 58-96) sensitivity and 81% (95% C.I. 42-96) specificity in predicting response status in the training set (area under curve, AUC, 0.81, p=0.02). In the validation set, baseline levels of s-Arg-1>205 ng/mL resulted in 83% (C.I. 95% 62-95) sensitivity and 87% (C.I. 95% 47-99) specificity in predicting response status. Patients with s-Arg-1 ≥ 205 ng/mL had shorter PFS than patients carrying Arg-1 < 205 ng/mL (despite both groups did not reach the median, because of the short follow-up, p=0.005). In first 10 patients enrolled in the study, semiquantitative parameters of PET at diagnosis were explored: SUVmax was 12.7 (range 5.9-14.2), MTV median was45.5 (range 8.9-308.7), TLG mean was 43.7 (range 25.2-2475.3). MTV and TLG, but not SUVmax, were positively correlated to s-Arg-1 (respectively, r=0.68, p=0.003 and r=0.59, p=0.002). Conclusion S-Arg-1 is a predictor of PFS in HL and it is positively correlated with MTV in PET scans at baseline calculated with a novel operator-independent tool for imaging analysis. An update will be provided at the conference. Disclosures No relevant conflicts of interest to declare." @default.
• W2575877568 created "2017-01-26" @default.
• W2575877568 creator A5015082674 @default.
• W2575877568 creator A5017020400 @default.
• W2575877568 creator A5018769545 @default.
• W2575877568 creator A5021392634 @default.
• W2575877568 creator A5022546252 @default.
• W2575877568 creator A5023090551 @default.
• W2575877568 creator A5023850717 @default.
• W2575877568 creator A5030208971 @default.
• W2575877568 creator A5034393745 @default.
• W2575877568 creator A5034992947 @default.
• W2575877568 creator A5038163660 @default.
• W2575877568 creator A5042250458 @default.
• W2575877568 creator A5045579010 @default.
• W2575877568 creator A5045741618 @default.
• W2575877568 creator A5065852754 @default.
• W2575877568 creator A5070046619 @default.
• W2575877568 creator A5072417532 @default.
• W2575877568 date "2014-12-06" @default.
• W2575877568 modified "2023-09-30" @default.
• W2575877568 title "Arginase-1 Is Increased in Hodgkin Lymphoma, Associated to Poor Outcome and Positively Correlated to Semiquantitative PET Parameters" @default.
• W2575877568 doi "https://doi.org/10.1182/blood.v124.21.4401.4401" @default.
• W2575877568 hasPublicationYear "2014" @default.
• W2575877568 type Work @default.
• W2575877568 sameAs 2575877568 @default.
• W2575877568 citedByCount "0" @default.
• W2575877568 crossrefType "journal-article" @default.
• W2575877568 hasAuthorship W2575877568A5015082674 @default.
• W2575877568 hasAuthorship W2575877568A5017020400 @default.
• W2575877568 hasAuthorship W2575877568A5018769545 @default.
• W2575877568 hasAuthorship W2575877568A5021392634 @default.
• W2575877568 hasAuthorship W2575877568A5022546252 @default.
• W2575877568 hasAuthorship W2575877568A5023090551 @default.
• W2575877568 hasAuthorship W2575877568A5023850717 @default.
• W2575877568 hasAuthorship W2575877568A5030208971 @default.
• W2575877568 hasAuthorship W2575877568A5034393745 @default.
• W2575877568 hasAuthorship W2575877568A5034992947 @default.
• W2575877568 hasAuthorship W2575877568A5038163660 @default.
• W2575877568 hasAuthorship W2575877568A5042250458 @default.
• W2575877568 hasAuthorship W2575877568A5045579010 @default.
• W2575877568 hasAuthorship W2575877568A5045741618 @default.
• W2575877568 hasAuthorship W2575877568A5065852754 @default.
• W2575877568 hasAuthorship W2575877568A5070046619 @default.
• W2575877568 hasAuthorship W2575877568A5072417532 @default.
• W2575877568 hasConcept C142724271 @default.
• W2575877568 hasConcept C164007495 @default.
• W2575877568 hasConcept C2775842073 @default.
• W2575877568 hasConcept C2777468819 @default.
• W2575877568 hasConcept C2779338263 @default.
• W2575877568 hasConcept C2989005 @default.
• W2575877568 hasConcept C515207424 @default.
• W2575877568 hasConcept C55493867 @default.
• W2575877568 hasConcept C71924100 @default.
• W2575877568 hasConcept C86803240 @default.
• W2575877568 hasConceptScore W2575877568C142724271 @default.
• W2575877568 hasConceptScore W2575877568C164007495 @default.
• W2575877568 hasConceptScore W2575877568C2775842073 @default.
• W2575877568 hasConceptScore W2575877568C2777468819 @default.
• W2575877568 hasConceptScore W2575877568C2779338263 @default.
• W2575877568 hasConceptScore W2575877568C2989005 @default.
• W2575877568 hasConceptScore W2575877568C515207424 @default.
• W2575877568 hasConceptScore W2575877568C55493867 @default.
• W2575877568 hasConceptScore W2575877568C71924100 @default.
• W2575877568 hasConceptScore W2575877568C86803240 @default.
• W2575877568 hasIssue "21" @default.
• W2575877568 hasLocation W25758775681 @default.
• W2575877568 hasOpenAccess W2575877568 @default.
• W2575877568 hasPrimaryLocation W25758775681 @default.
• W2575877568 hasRelatedWork W1965701482 @default.
• W2575877568 hasRelatedWork W2007765177 @default.
• W2575877568 hasRelatedWork W2068434134 @default.
• W2575877568 hasRelatedWork W2143881498 @default.
• W2575877568 hasRelatedWork W2165645825 @default.
• W2575877568 hasRelatedWork W2171632483 @default.
• W2575877568 hasRelatedWork W2186028194 @default.
• W2575877568 hasRelatedWork W2336271842 @default.
• W2575877568 hasRelatedWork W2343460345 @default.
• W2575877568 hasRelatedWork W3021040965 @default.
• W2575877568 hasVolume "124" @default.
• W2575877568 isParatext "false" @default.
• W2575877568 isRetracted "false" @default.
• W2575877568 magId "2575877568" @default.
• W2575877568 workType "article" @default.